AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 253: R832-R837, 1987;
0363-6119/87 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Merrill, D. C.
Right arrow Articles by Cowley, A. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Merrill, D. C.
Right arrow Articles by Cowley, A. W., Jr

AJP - Regulatory, Integrative and Comparative Physiology, Vol 253, Issue 6 832-R837, Copyright © 1987 by American Physiological Society


ARTICLES

Angiotensin II sensitization of aldosterone responsiveness to plasma sodium in conscious dogs

D. C. Merrill, M. M. Skelton and A. W. Cowley Jr
Department of Physiology, Medical College of Wisconsin, Milwaukee 53226.

Studies were performed to quantify the interaction of angiotensin II (ANG II) and plasma sodium (Na+) on the adrenal gland's ability to secrete aldosterone (Aldo). Two groups of normal conscious dogs were used in which plasma Na+ was independently elevated in the face of differing background levels of ANG II. In group 1 (n = 6), plasma Na+ was increased progressively over a 1-h period (from 143 +/- 1 to 152 +/- 1.2 meq/l), whereas plasma K+ was maintained at a constant level by intravenous infusion. With low background levels of ANG II (0.5 ng.kg-1.min-1), plasma Aldo remained unchanged with the increase in plasma Na+. With high ANG II (20.0 ng.kg-1.min-1), plasma Na+ changed in a similar manner (143.1 +/- 1.2 to 154.3 +/- 0.7 meq/l), whereas plasma Aldo decreased progressively from 35.3 +/- 2.3 to 27.9 +/- 3.8 ng/dl (P less than 0.05). In group 2 (n = 5), plasma Na+ was increased abruptly (144.9 +/- 0.6 to 152.1 +/- 0.5) and maintained at the elevated level for 3 h, and plasma K+ was held constant. Again, at low steady-state levels of ANG II (0.5 ng.kg-1.min-1), plasma Aldo levels remained unchanged. But, at intermediate levels of ANG II (5.0 ng-kg-1.min-1), producing plasma ANG II levels similar to those seen with dietary NaCl restriction, plasma Aldo decreased from 20.4 +/- 4.3 to 9.0 +/- 1.3 ng/dl (P less than 0.05). This rate of infused ANG II has been shown to result in plasma ANG II levels similar to that seen with dietary NaCl restriction. At the highest dose of ANG II (20 ng.kg-1.min-1), the ability of plasma Na+ to lower plasma Aldo was blunted to the extent that the decrease from 27.5 +/- 2.2 to 21.3 +/- 1.6 was not statistically significant. These studies indicate that physiological elevation of ANG II appears to sensitize the adrenal aldosterone responsiveness to changes in plasma Na+.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online